The standardized RT-qPCR protocol for quantifying NF-κB p65 expression has a wide range of clinical and research applications, particularly for monitoring diseases characterized by NF-κB activation, such as HIV-1 infection, chronic inflammatory conditions, and cancers. This evidence concerns the gene NFKB1 and HIV-1 infection.